Annual Working Capital
$239.05 M
-$13.87 M-5.48%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual working capital is $239.05 million, with the most recent change of -$13.87 million (-5.48%) on December 31, 2023.
- During the last 3 years, INBX annual working capital has risen by +$138.27 million (+137.21%).
- INBX annual working capital is now -5.48% below its all-time high of $252.92 million, reached on December 31, 2022.
Performance
INBX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$163.35 M
-$39.65 M-19.53%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly working capital is $163.35 million, with the most recent change of -$39.65 million (-19.53%) on September 30, 2024.
- Over the past year, INBX quarterly working capital has dropped by -$39.65 million (-19.53%).
- INBX quarterly working capital is now -50.13% below its all-time high of $327.53 million, reached on September 30, 2023.
Performance
INBX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
INBX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -19.5% |
| 3 y3 years | +137.2% | -22.6% |
| 5 y5 years | +2371.2% | -22.6% |
INBX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.5% | +104.9% | -50.1% | +773.7% |
| 5 y | 5-year | -5.5% | +4872.3% | -50.1% | +773.7% |
| alltime | all time | -5.5% | +2371.2% | -50.1% | +773.7% |
Inhibrx Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $163.35 M(-19.5%) |
| Jun 2024 | - | $203.00 M(-937.2%) |
| Mar 2024 | - | -$24.25 M(+25.0%) |
| Dec 2023 | $239.05 M(-5.5%) | -$19.40 M(-105.9%) |
| Sep 2023 | - | $327.53 M(+90.4%) |
| Jun 2023 | - | $171.99 M(-18.5%) |
| Mar 2023 | - | $211.14 M(-16.5%) |
| Dec 2022 | $252.92 M(+116.8%) | $252.92 M(+97.1%) |
| Sep 2022 | - | $128.33 M(-18.5%) |
| Jun 2022 | - | $157.42 M(+20.8%) |
| Mar 2022 | - | $130.30 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $116.66 M(+15.8%) | $116.66 M(+24.3%) |
| Sep 2021 | - | $93.88 M(-14.3%) |
| Jun 2021 | - | $109.61 M(+28.1%) |
| Mar 2021 | - | $85.55 M(-15.1%) |
| Dec 2020 | $100.77 M(-2111.8%) | $100.77 M(+3.8%) |
| Sep 2020 | - | $97.11 M(-562.9%) |
| Jun 2020 | - | -$20.98 M(+318.8%) |
| Dec 2019 | -$5.01 M(-52.4%) | -$5.01 M(-125.9%) |
| Jun 2019 | - | $19.31 M(-373.0%) |
| Mar 2019 | - | -$7.07 M |
| Dec 2018 | -$10.53 M(-261.4%) | - |
| Dec 2017 | $6.52 M | - |
FAQ
- What is Inhibrx Biosciences annual working capital?
- What is the all time high annual working capital for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual working capital year-on-year change?
- What is Inhibrx Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly working capital year-on-year change?
What is Inhibrx Biosciences annual working capital?
The current annual working capital of INBX is $239.05 M
What is the all time high annual working capital for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual working capital is $252.92 M
What is Inhibrx Biosciences annual working capital year-on-year change?
Over the past year, INBX annual working capital has changed by -$13.87 M (-5.48%)
What is Inhibrx Biosciences quarterly working capital?
The current quarterly working capital of INBX is $163.35 M
What is the all time high quarterly working capital for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly working capital is $327.53 M
What is Inhibrx Biosciences quarterly working capital year-on-year change?
Over the past year, INBX quarterly working capital has changed by -$39.65 M (-19.53%)